Tenderwize
Retour à la recherche

Open House Discount Contracts for Omalizumab

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 132 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Omalizumab, ATC R03DX05

30/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

30 / 100

Complexité

20 / 100

Facteurs de risque

No indication of expected sales volume or number of patients; the discount may not generate significant revenue.

The buyer may replace open house contracts with exclusive ones from a separate tender, automatically ending all open ho...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Feb 28, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of non-exclusive discount contracts (Rabattverträge) under German Social Code (§§ 130a Abs. 8/130c Abs. 1 SGB V) for Omalizumab.
  • Contracts are open to all pharmaceutical companies that supply authorized and marketable Omalizumab products in Germany.
Afficher le résumé complet

Open house (non-exclusive) discount contracts for pharmaceutical products containing the active substance Omalizumab (ATC R03DX05), offered by AOK Rheinland-Pfalz/Saarland. The model allows any interested pharmaceutical company to enter into a standard agreement at any time during the 24-month period (May 2025 – April 2027). No competitive selection; all qualified applicants are accepted. The first contracts start 1 May 2025; initial application deadline is 31 March 2025. Later enrollments are possible monthly. The buyer may replace these non-exclusive contracts with exclusive ones during the term. The notice is published voluntarily for transparency; it is not a public procurement under EU directives.

Risques

No indication of expected sales volume or number of patients; the discount may not generate significant revenue.

The buyer may replace open house contracts with exclusive ones from a separate tender, automatically ending all open ho...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Provide authorized and marketable Omalizumab products in Germany (proof via Lauer-Taxe listing or AMIce database extracts).

Administrative

  • Submit signed contract documents and required annexes by applicable deadline.
  • No electronic submission; paper documents required (original by mail or courier).

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria defined; all eligible participants are accepted.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open House Discount Contracts for Omalizumab

Non-exclusive framework discount contracts for Omalizumab (ATC R03DX05). All pharmaceutical companies with authorized and marketable products in Germany can join. Standard terms, no negotiation. Max duration 24 months from earliest start (May 2025). Contracts end automatically if replaced by exclusive contracts from a separate tender.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria defined; all eligible participants are accepted.

Date limite

Deadline Feb 28, 2027

Détails de la procédure

Date de publication
12 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
163311-2025

Documents (1)

Appels d'offres similaires